France Dube, Director of Global Oncology Policy, Precision Medicine and Breast Cancer at AstraZeneca, shared a post on LinkedIn:
“Proud to share that the Breast Cancer Care Quality Index (BCCQI) Call to Action (CTA) is now published and ready to accelerate change!
Breast cancer is the leading cause of cancer death among women worldwide. If current trends continue, we could see 3.2 million new breast cancer cases and 1.1 million related deaths each year by 2050. The impact is profound – on health, household stability, productivity, equity, social well‑being, and already‑stretched health systems.
The WHO set a target to reduce breast cancer mortality by 2.5% annually – but too few countries are on track. This must change, and we must act now.
Last year, global, cross-sector experts launched the Breast Cancer Care Quality Index (BCCQI) – an aligned, actionable and flexible evidence-based framework to improve the quality of breast cancer care – across four critical dimensions:
- Early detection
- Timely diagnosis
- Comprehensive management
- Healthcare system resilience & strength
Now, the BCCQI CTA offers practical guidance to help countries set priorities, coordinate efforts, and build actionable roadmaps based on the BCCQI framework that translate into measurable improvements and high-quality care for all women.
At AstraZeneca, we are driven by the ambition to one day eliminate cancer as a cause of death – and initiatives like the BCCQI reflect the collective responsibility we share to turn that ambition into real impact for patients.
You can read the full BCCQI publication here”
Title: Improving Breast Cancer Outcomes Through Quality Care: Call to Action for the Implementation of the Breast Cancer Care Quality Index (BCCQI)
Authors: Maira Caleffi, Mary Ajango, Aydah M. Al-Awadhi, Ricki Fairley, Andrea B. Feigl, Ana Rita González, Victoria Harmer, Naveena Nekkalapudi, Toyin Saraki, Victoria Wolodzko Smart, Araceli Fernandez-Cerdeño, João Victor Rocha, Ilaria Lucibello and Namita Srivastava
Other articles featuring France Dube on OncoDaily.